Treatment News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News


December 21, 2012
New HIV Vaccine Is Safe and Boosts Immune Reaction in Phase I Trial
An investigatory vaccine from the Baltimore-based Profectus BioSciences is both safe in humans and prompts an immune response to HIV proteins.
December 20, 2012
Certain Meds Mixed With Grapefruit Juice Can Be a Fatal Cocktail
The scientist who discovered that grapefruit can alter  drug levels in the body has released an updated list of 85 medications that may cause such reactions.
December 19, 2012
HIV-Positive Smokers Lose Far More Years to Cigarettes Than to the Virus
A large study has found that smokers with well-controlled HIV lose far more years of life expectancy to cigarettes than to the virus.
FDA Gives Hep C Drug Incivek 'Black Box' Warning for Causing Fatal Skin Reactions
Vertex Pharmaceuticals’ hepatitis C antiviral Incivek (telaprevir) has caused a number of deaths due to serious skin reactions.
December 18, 2012
ViiV Files Regulatory Applications for New Integrase Inhibitor Dolutegravir
ViiV Healthcare announced it has filed regulatory applications for the company’s investigational HIV integrase inhibitor dolutegravir.
December 17, 2012
HIV and Hepatitis C Coinfection Raises Cognitive Impairment Risk for Men
HIV and Hepatitis Coinfection Raises Cognitive Impairment Risk for Men
December 14, 2012
Proof of Principle for a New HIV Microbicide in Study Among Primates
New research has achieved a proof of principle that an investigatory microbicide gel is highly effective at preventing vaginal transmission of HIV.
December 13, 2012
The FDA Recommends Fast-Track Approval for TB Therapy in New Drug Class
The the FDA's Anti-Infective Drugs Advisory Committee has recommended accelerated approval for bedaquiline, the first in a new class of TB therapy.
December 12, 2012
Electronic Reminders to HIV Providers Improve Patient Outcomes
Computerized alerts to health care providers about their HIV patients improved patient outcomes in a study of one large clinic in Boston.
December 11, 2012
Universal HIV Therapy Supresses Viral Loads in Those With CD4s Above 500
Universally recommending HIV therapy significantly increases the likelihood of viral suppression among those with CD4 counts above 500.
December 10, 2012
HIV Docs Believe Meds Prevent Transmission, But Don’t Start ARVs Early
HIV clinicians widely believe that antiretroviral treatment can prevent transmission, but only one in seven immediately starts treatment in patients.
December 07, 2012
A New HIV and Pregnancy Prevention Tool: Electrically Spun Fibers
Researchers have found that electrically spun cloth can create both a chemical and physical barrier to prevent both pregnancy and HIV transmission.
December 06, 2012
Chinese Study Challenges Treatment as Prevention Strategy
A large Chinese study claims that treating HIV is much less effective at preventing transmission among serodiscordant couples than previously believed. 
December 05, 2012
Low Vitamin D Hinders CD4 Gains in Women Starting HIV Treatment Late
Women who start HIV treatment late in the course of their infection gain fewer CD4 cells if they have insufficient vitamin D levels.
December 04, 2012
Low Bone Mineral Density in Gay Men Not Due to HIV
The prevalence of low bone mineral density (BMD) among HIV-positive gay men is not significantly related to the virus, but caused by other risk factors.
December 03, 2012
Gene That Helps Embryos Survive Could Fight HIV, Hep B and TB
A newly discovered gene crucial for the survival of embryos may become instrumental in the fight against chronic infections, including HIV, hepatitis B and TB.
U.S. Task Force Declines to Press for Widespread Baby Boomer Hep C Screens
The U.S. Preventive Services Task Force has refrained from recommending that all baby boomers undergo screening for hepatitis C virus.
More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ



Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    acousticmat
    Tucson
    Arizona


    juliar33
    brooklyn
    New York


    TaintedloveDC
    Washington
    DC


    donnyp
    liberty
    Kentucky
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.